Consolidated Statements of Operations and Comprehensive Loss - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018	Jun. 30, 2017
Net revenues	$ 4,334,000	$ 9,003,000	$ 14,217,000
Net revenues – related party	1,679,000	669,000	308,000
Total net revenues	6,013,000	9,672,000	14,525,000
Cost of revenues	3,858,000	7,479,000	8,686,000
Gross profit	2,155,000	2,193,000	5,839,000
Expenses:
Sales and marketing	935,000	1,359,000	1,531,000
Research and development	2,246,000	3,012,000	2,497,000
General and administrative	3,572,000	8,286,000	10,870,000
Impairment charges		33,081,000	310,000
Total operating expenses	6,753,000	45,738,000	15,208,000
Loss from operations	(4,598,000)	(43,545,000)	(9,369,000)
Other income (expense):
Interest expense	(541,000)	(2,697,000)	(20,519,000)
Fair value change of derivative instruments	133,000	596,000	(60,000)
Other income and (expenses)	(2,000)	(24,000)	180,000
Total other expense	(410,000)	(2,125,000)	(20,399,000)
Loss before benefit for income taxes	(5,008,000)	(45,670,000)	(29,768,000)
Benefit for income taxes	2,238,000	4,730,000	673,000
Net loss	(2,770,000)	(40,940,000)	(29,095,000)
Loss attributable to non-controlling interests	(487,000)	(1,224,000)
Net loss attributable to common stockholders	(2,283,000)	(39,716,000)	(29,095,000)
Other comprehensive loss:
Net loss	(2,770,000)	(40,940,000)	(29,095,000)
Foreign currency translation	(5,000)	30,000	(1,000)
Comprehensive loss	(2,775,000)	(40,910,000)	(29,096,000)
Comprehensive loss attributable to non-controlling interests	(487,000)	(1,224,000)
Comprehensive loss attributable to common stockholders	$ (2,288,000)	$ (39,686,000)	$ (29,096,000)
Per share data:
Basic and diluted net loss per common share (in dollars per share)	$ (0.23)	$ (2.16)	$ (3.27)
Weighted average common shares outstanding – Basic and diluted (in shares)	10,108,329	18,412,807	8,904,508